129 related articles for article (PubMed ID: 31729215)
1. New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053.
Chiarelli LR; Salina EG; Mori G; Azhikina T; Riabova O; Lepioshkin A; Grigorov A; Forbak M; Madacki J; Orena BS; Manfredi M; Gosetti F; Buzzi A; Degiacomi G; Sammartino JC; Marengo E; Korduláková J; Riccardi G; Mikušová K; Makarov V; Pasca MR
ACS Infect Dis; 2020 Feb; 6(2):313-323. PubMed ID: 31729215
[TBL] [Abstract][Full Text] [Related]
2. Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug.
Mori G; Orena BS; Chiarelli LR; Degiacomi G; Riabova O; Sammartino JC; Makarov V; Riccardi G; Pasca MR
Front Microbiol; 2020; 11():292. PubMed ID: 32158439
[TBL] [Abstract][Full Text] [Related]
3. Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis.
Albesa-Jové D; Chiarelli LR; Makarov V; Pasca MR; Urresti S; Mori G; Salina E; Vocat A; Comino N; Mohorko E; Ryabova S; Pfieiffer B; Lopes Ribeiro AL; Rodrigo-Unzueta A; Tersa M; Zanoni G; Buroni S; Altmann KH; Hartkoorn RC; Glockshuber R; Cole ST; Riccardi G; Guerin ME
ACS Chem Biol; 2014 Jul; 9(7):1567-75. PubMed ID: 24877756
[TBL] [Abstract][Full Text] [Related]
4. The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of
Rosado LA; Wahni K; Degiacomi G; Pedre B; Young D; de la Rubia AG; Boldrin F; Martens E; Marcos-Pascual L; Sancho-Vaello E; Albesa-Jové D; Provvedi R; Martin C; Makarov V; Versées W; Verniest G; Guerin ME; Mateos LM; Manganelli R; Messens J
J Biol Chem; 2017 Aug; 292(32):13097-13110. PubMed ID: 28620052
[TBL] [Abstract][Full Text] [Related]
5. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.
Singh R; Manjunatha U; Boshoff HI; Ha YH; Niyomrattanakit P; Ledwidge R; Dowd CS; Lee IY; Kim P; Zhang L; Kang S; Keller TH; Jiricek J; Barry CE
Science; 2008 Nov; 322(5906):1392-5. PubMed ID: 19039139
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis.
Hartkoorn RC; Ryabova OB; Chiarelli LR; Riccardi G; Makarov V; Cole ST
Antimicrob Agents Chemother; 2014 May; 58(5):2944-7. PubMed ID: 24550336
[TBL] [Abstract][Full Text] [Related]
7. SigH stress response mediates killing of Mycobacterium tuberculosis by activating nitronaphthofuran prodrugs via induction of Mrx2 expression.
Cioetto-Mazzabò L; Boldrin F; Beauvineau C; Speth M; Marina A; Namouchi A; Segafreddo G; Cimino M; Favre-Rochex S; Balasingham S; Trastoy B; Munier-Lehmann H; Griffiths G; Gicquel B; Guerin ME; Manganelli R; Alonso-Rodríguez N
Nucleic Acids Res; 2023 Jan; 51(1):144-165. PubMed ID: 36546765
[TBL] [Abstract][Full Text] [Related]
8. Update of Antitubercular Prodrugs from a Molecular Perspective: Mechanisms of Action, Bioactivation Pathways, and Associated Resistance.
Laborde J; Deraeve C; Bernardes-Génisson V
ChemMedChem; 2017 Oct; 12(20):1657-1676. PubMed ID: 28921911
[TBL] [Abstract][Full Text] [Related]
9. The Redox State Regulates the Conformation of Rv2466c to Activate the Antitubercular Prodrug TP053.
Albesa-Jové D; Comino N; Tersa M; Mohorko E; Urresti S; Dainese E; Chiarelli LR; Pasca MR; Manganelli R; Makarov V; Riccardi G; Svergun DI; Glockshuber R; Guerin ME
J Biol Chem; 2015 Dec; 290(52):31077-89. PubMed ID: 26546681
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorA.
Lopez Quezada L; Silve S; Kelinske M; Liba A; Diaz Gonzalez C; Kotev M; Goullieux L; Sans S; Roubert C; Lagrange S; Bacqué E; Couturier C; Pellet A; Blanc I; Ferron M; Debu F; Li K; Aubé J; Roberts J; Little D; Ling Y; Zhang J; Gold B; Nathan C
mBio; 2019 Jul; 10(4):. PubMed ID: 31289182
[TBL] [Abstract][Full Text] [Related]
11. Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.
Gold B; Roberts J; Ling Y; Quezada LL; Glasheen J; Ballinger E; Somersan-Karakaya S; Warrier T; Warren JD; Nathan C
Antimicrob Agents Chemother; 2015 Oct; 59(10):6521-38. PubMed ID: 26239979
[TBL] [Abstract][Full Text] [Related]
12. Pretomanid for the treatment of pulmonary tuberculosis.
Thakare R; Dasgupta A; Chopra S
Drugs Today (Barc); 2020 Oct; 56(10):655-668. PubMed ID: 33185630
[TBL] [Abstract][Full Text] [Related]
13. Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis.
Segretti ND; Simões CK; Corrêa MF; Felli VMA; Miyata M; Cho SH; Franzblau SG; Fernandes JPDS
Tuberculosis (Edinb); 2016 Jul; 99():11-16. PubMed ID: 27449999
[TBL] [Abstract][Full Text] [Related]
14. Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance.
de Carvalho LP; Lin G; Jiang X; Nathan C
J Med Chem; 2009 Oct; 52(19):5789-92. PubMed ID: 19736929
[TBL] [Abstract][Full Text] [Related]
15. A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.
Gold B; Warrier T; Nathan C
Methods Mol Biol; 2021; 2314():611-635. PubMed ID: 34235673
[TBL] [Abstract][Full Text] [Related]
16. Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liver.
Dogra M; Palmer BD; Bashiri G; Tingle MD; Shinde SS; Anderson RF; O'Toole R; Baker EN; Denny WA; Helsby NA
Br J Pharmacol; 2011 Jan; 162(1):226-36. PubMed ID: 20955364
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).
Cherian J; Choi I; Nayyar A; Manjunatha UH; Mukherjee T; Lee YS; Boshoff HI; Singh R; Ha YH; Goodwin M; Lakshminarayana SB; Niyomrattanakit P; Jiricek J; Ravindran S; Dick T; Keller TH; Dartois V; Barry CE
J Med Chem; 2011 Aug; 54(16):5639-59. PubMed ID: 21755942
[TBL] [Abstract][Full Text] [Related]
18. Fighting tuberculosis by drugs targeting nonreplicating
Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
Int J Mycobacteriol; 2017; 6(3):213-221. PubMed ID: 28776518
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
20. A New Benzothiazolthiazolidine Derivative, 11726172, Is Active
Salina EG; Postiglione U; Chiarelli LR; Recchia D; Záhorszká M; Lepioshkin A; Monakhova N; Pál A; Porta A; Zanoni G; Korduláková J; Kazakova E; Sassera D; Pasca MR; Makarov V; Degiacomi G
mSphere; 2022 Dec; 7(6):e0036922. PubMed ID: 36377880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
